The International Rare Diseases Research Consortium (IRDiRC) is proud to announce that the commentary on 10 years of progress and challenges of IRDiRC that was previously published in the prestigious journalNature Reviews Drug Discovery is now fully available for reading.
The article summarizes IRDiRC’s vision and goals and highlights its achievements and prospects after its first decade (2011–2021).
The commentary has been authored by Lucia Monaco (Consortium Assembly Chair 2018–2021) along with Galliano Zanello, Gareth Baynam, Anneliene H. Jonker, Daria Julkowska, Adam L. Hartman, Daniel O’Connor, Chiuhui Mary Wang, Durhane Wong-Rieger, and David A. Pearce.
The supplementary information included with the commentary provides a visual summary of IRDiRC’s vision and goals, its international reach, the organization of its committees, Working Groups, and Task Forces, an overview of communication activities, and rare disease metrics.
The full article is available here.
The supplementary information can be downloaded from here.